Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-14

Clinical Trial Update: Investigational Study of Delayed Release Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial of delayed-release metformin for type 2 diabetes is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • delayed-release metformin (metformin)

Snippet

Sponsor: Anji Pharma | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: SUSPENDED